Guided Therapeutics (GTHP) Other Non-Current Assets (2014 - 2025)
Guided Therapeutics recorded quarterly Other Non-Current Assets of $17000.0 in Q4 2025, little changed quarter-over-quarter from $17000.0 in Q3 2025, and little changed year-over-year from $17000.0 in Q4 2024.
Guided Therapeutics' Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $17000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $17000.0; the TTM figure through Dec 2025 stood at $17000.0 (changed 0.0% YoY), while the FY2025 annual figure was $17000.0, changed 0.0% from the prior year.
- Other Non-Current Assets came in at $17000.0 for Q4 2025 at Guided Therapeutics, roughly flat from $17000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $18000.0 in Q1 2021 to a low of $17000.0 in Q2 2021.
- A 5-year average of $17050.0 and a median of $17000.0 in 2021 frame the typical range for Other Non-Current Assets.
- On a YoY basis, Other Non-Current Assets climbed as much as 5.88% in 2021 and fell as far as 96.55% in 2021.
- Guided Therapeutics' Other Non-Current Assets stood at $17000.0 in 2021, then changed by 0.0% to $17000.0 in 2022, then changed by 0.0% to $17000.0 in 2023, then changed by 0.0% to $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $17000.0, $17000.0, and $17000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Mar 31, 2021 | 18,000.00 |
| Sep 30, 2020 | 493,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 18,000.00 |
| Jun 30, 2019 | 19,000.00 |
| Mar 31, 2019 | 19,000.00 |
| Dec 31, 2018 | 19,000.00 |
| Sep 30, 2018 | 17,000.00 |
| Jun 30, 2018 | 18,000.00 |
| Mar 31, 2018 | 18,000.00 |
| Dec 31, 2017 | 60,000.00 |
| Sep 30, 2017 | 19,000.00 |
| Dec 31, 2016 | 320,000.00 |
| Dec 31, 2015 | 48,000.00 |
| Dec 31, 2014 | 564,000.00 |